BamSEC and AlphaSense Join Forces
Learn More

Latigo Biotherapeutics Inc. – Material Contracts

NASDAQ: LTGO    
Share price (11/6/26): $12.60    
Market cap (11/6/26): $835 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.7
from S-1/A 2 pages Latigo Biotherapeutics, Inc. Non-Employee Director Compensation Policy Adopted: June 17, 2026
12/34/56
EX-10.6
from S-1/A 14 pages Latigo Biotherapeutics, Inc. 2026 Employee Stock Purchase Plan Adopted by the Board of Directors: June 17, 2026 Approved by the Stockholders: July 28, 2026
12/34/56
EX-10.4
from S-1/A 30 pages Latigo Biotherapeutics, Inc. 2026 Equity Incentive Plan Adopted by the Board of Directors: June 17, 2026 Approved by the Stockholders: July 28, 2026
12/34/56
EX-10.16
from S-1 3 pages May 26, 2026 Todd Smith Re: Board of Directors of Latigo Biotherapeutics, Inc. Dear Todd: It Is My Sincere Pleasure to Offer You a Position as a Member of the Board of Directors (The “Board”) of Latigo Biotherapeutics, Inc. (The “Company”). We Believe That Your Experience and Background Will Be of Great Benefit to the Company
12/34/56
EX-10.15
from S-1 3 pages March 20, 2026 Sara Bonstein Re: Board of Directors of Latigo Biotherapeutics, Inc. Dear Sara
12/34/56
EX-10.14
from S-1 15 pages Latigo Biotherapeutics, Inc. Severance Plan and Summary Plan Description Approved by the Board of Directors: July 13, 2026
12/34/56
EX-10.13
from S-1 6 pages Latigo Biotherapeutics, Inc. Executive Employment Agreement for Neha Krishnamohan
12/34/56
EX-10.12
from S-1 6 pages Latigo Biotherapeutics, Inc. Executive Employment Agreement for Neil Singla, M.D
12/34/56
EX-10.11
from S-1 6 pages Latigo Biotherapeutics, Inc. Executive Employment Agreement for Nima Farzan
12/34/56
EX-10.10
from S-1 40 pages License Agreement
12/34/56
EX-10.9
from S-1 3 pages October 25, 2024 Timothy P. Walbert Re: Independent Chair Position on the Board of Directors of Latigo Biotherapeutics, Inc. Dear Tim: It Is My Sincere Pleasure to Offer You the Opportunity to Join the Board of Directors (The “Board”) of Latigo Biotherapeutics, Inc. (The “Company”) as Its Independent Chair
12/34/56
EX-10.8
from S-1 10 pages Re: Separation Agreement Dear Tim: This Letter Sets Forth the Substance of the Separation Agreement (The “Agreement”) That Latigo Biotherapeutics, Inc. (The “Company”) Is Offering to You to Aid in Your Employment Transition. 1. Separation. Your Employment Termination Date Will Be January 30, 2026 (The “Separation Date”). You Understand and Agree That You Are Not Authorized to Hold Yourself Out as Being Employed or Affiliated With the Company in Any Way Following the Separation Date
12/34/56
EX-10.6
from S-1 14 pages Latigo Biotherapeutics, Inc. 2026 Employee Stock Purchase Plan Adopted by the Board of Directors: June 17, 2026 Approved by the Stockholders: [ ]
12/34/56
EX-10.5
from S-1 10 pages Latigo Biotherapeutics, Inc. Stock Option Grant Notice
12/34/56
EX-10.4
from S-1 30 pages Latigo Biotherapeutics, Inc. 2026 Equity Incentive Plan Adopted by the Board of Directors: June 17, 2026 Approved by the Stockholders: [ ]
12/34/56
EX-10.3
from S-1 53 pages Latigo Biotherapeutics, Inc. 2019 Stock Plan Notice of Stock Option Grant
12/34/56
EX-10.2
from S-1 17 pages Latigo Biotherapeutics, Inc. 2019 Stock Plan Adopted on December 23, 2019
12/34/56
EX-10.1
from S-1 8 pages Indemnification Agreement
12/34/56
EX-10.14
from DRS 40 pages License Agreement
12/34/56
EX-10.13
from DRS 3 pages October 25, 2024 Timothy P. Walbert Re: Independent Chair Position on the Board of Directors of Latigo Biotherapeutics, Inc. Dear Tim: It Is My Sincere Pleasure to Offer You the Opportunity to Join the Board of Directors (The “Board”) of Latigo Biotherapeutics, Inc. (The “Company”) as Its Independent Chair
12/34/56